**Core Concept**
The question is testing the side effect profile of alosetron, a 5-HT3 antagonist drug, which is used primarily for the treatment of severe diarrhea-predominant irritable bowel syndrome (IBS-D). Alosetron works by antagonizing the 5-HT3 receptors in the gastrointestinal tract, thereby reducing bowel movement frequency and urgency.

**Why the Correct Answer is Right**
Alosetron's mechanism of action involves blocking the 5-HT3 receptors on the enteric nervous system, which are involved in the regulation of gut motility and secretion. By antagonizing these receptors, alosetron reduces the frequency and urgency of bowel movements, providing relief to patients with IBS-D. However, this action also leads to a common side effect, which is related to its mechanism of action.

**Why Each Wrong Option is Incorrect**
* **Option A:** Alosetron's most common side effect is not constipation, although it may be a consequence of its mechanism of action. Constipation is a possible side effect, but it's not the most common one.
* **Option B:** Alosetron is not associated with an increased risk of colon cancer. In fact, its mechanism of action is aimed at reducing bowel movement frequency, which could potentially decrease the risk of colon cancer.
* **Option C:** Alosetron is not commonly associated with an increased risk of cardiovascular events. Its side effect profile is more related to gastrointestinal issues, rather than cardiovascular risks.

**Clinical Pearl / High-Yield Fact**
Alosetron has a black box warning due to its potential to cause severe constipation and ischemic colitis, which can be life-threatening in some cases. This highlights the importance of careful patient selection and monitoring when prescribing this medication.

**Correct Answer: C. Ischemic colitis**